Mutation analysis and clinical implications of von Willebrand factor–cleaving protease deficiency
- 1 June 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (6), 1995-1999
- https://doi.org/10.1046/j.1523-1755.63.6s.1.x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpuraBlood, 2002
- Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpuraNature, 2001
- Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiencyPediatric Nephrology, 2000
- Structure and Function of von Willebrand FactorThrombosis and Haemostasis, 1999
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.Proceedings of the National Academy of Sciences, 1990
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigenThrombosis Research, 1985
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1982